Codexis (CDXS) EBT Margin Growth (5y) (2015 - 2026)
Codexis (CDXS) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Codexis | 135.70 Mn | 70.56 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -657.00 |
| Dec 31, 2025 | 4,332.00 |
| Sep 30, 2025 | -19,492.00 |
| Jun 30, 2025 | -4,619.00 |
| Mar 31, 2025 | -22,199.00 |
| Dec 31, 2024 | -4,496.00 |
| Sep 30, 2024 | -16,229.00 |
| Jun 30, 2024 | -23,237.00 |
| Mar 31, 2024 | -3,439.00 |
| Dec 31, 2023 | -14,011.00 |
| Sep 30, 2023 | -36,446.00 |
| Jun 30, 2023 | -20,261.00 |
| Mar 31, 2023 | -14,065.00 |
| Dec 31, 2022 | -6,712.00 |
| Sep 30, 2022 | 7,196.00 |
| Jun 30, 2022 | 5,451.00 |
| Mar 31, 2022 | 10,950.00 |
| Dec 31, 2021 | 1,170.00 |
| Sep 30, 2021 | -31,652.00 |
| Jun 30, 2021 | -35,305.00 |